Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biocryst Pharma Inc
(NQ:
BCRX
)
4.450
-0.030 (-0.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biocryst Pharma Inc
< Previous
1
2
3
4
5
6
Next >
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript
February 21, 2023
BCRX earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Sliding Today
February 21, 2023
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported worse-than-expected earnings results<
Via
Benzinga
Biocryst Pharmaceuticals's Earnings Outlook
February 20, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
BioCryst Shelves Development Of Rare Blood Disorder Candidate
December 15, 2022
Via
Benzinga
Expert Ratings for BioCryst Pharmaceuticals
November 02, 2022
Analysts have provided the following ratings for BioCryst Pharmaceuticals (NASDAQ:BCRX) within the last quarter:
Via
Benzinga
BioCryst Pharmaceuticals Stock Is Tumbling: What's Going On?
January 09, 2023
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Monday after the company announced preliminary fourth-quarter and full
Via
Benzinga
TSLA Stock Price Prediction: What to Know as Analysts Slash Tesla Price Targets
December 15, 2022
Tesla (TSLA) stock is in the news as price predictions continue to be a hot topic among traders after Elon Musk's Twitter purchase.
Via
InvestorPlace
Why Is Getaround (GETR) Stock Up 6% Today?
December 15, 2022
Getaround (GETR) stock is on the move Thursday with heavy trading despite a lack of recent news concerning the car-sharing service.
Via
InvestorPlace
BCRX Stock Sinks as BioCryst Discontinues Drug Development
December 15, 2022
BioCryst Pharmaceuticals (BCRX) stock is falling on Thursday after revealing it's no longer developing BCX9930 for competitive reasons.
Via
InvestorPlace
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 15, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2022 Earnings Call Transcript
November 01, 2022
BCRX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
December 05, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
November 11, 2022
The Relative Strength (RS) Rating for BioCryst Pharmaceuticals stock climbed into a new percentile Friday, with a rise from 64 to 84.
Via
Investor's Business Daily
4 Analysts Have This to Say About BioCryst Pharmaceuticals
November 02, 2022
Within the last quarter, BioCryst Pharmaceuticals (NASDAQ:BCRX) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Upgrades
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
November 01, 2022
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Via
Benzinga
Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
November 01, 2022
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
What's Going On With BioCryst Pharmaceuticals Stock Today?
November 01, 2022
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported third-quarter financial results.
Via
Benzinga
BioCryst Pharmaceuticals: Q3 Earnings Insights
November 01, 2022
BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
October 20, 2022
Despite enthusiasm in some camps, the risk of potential cures clouds market projections.
Via
Investor's Business Daily
BioCryst Pharmaceuticals Stock Shows Rising Relative Strength
October 10, 2022
On Monday, BioCryst Pharmaceuticals stock received an upgrade to its Relative Strength (RS) Rating, from 90 to 93.
Via
Investor's Business Daily
Kalvista Crashes Nearly 60% After Adding HAE Drug To The Scrap Heap
October 04, 2022
The company scrapped its hereditary angioedema drug due to safety issues.
Via
Investor's Business Daily
3 Biotech Stocks to Buy Now for Extraordinary Gains
September 20, 2022
These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.
Via
InvestorPlace
BioCryst Secures FDA Orphan Drug Status For Rare Connective Tissue Disease Candidate
August 31, 2022
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for BioCryst’s (NASDAQ: BCRX) lead asset BCX9250 for the treatment of fibrodysplasia ossificans progressiva (FOP).
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
Via
Benzinga
BioCryst Exhibits Positive Data From Early-Stage Rare Kidney Disease Study
August 26, 2022
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced that its lead asset BCX9930 has demonstrated >99 percent suppression of the alternative pathway (AP), and that >98 percent suppression was maintained...
Via
Benzinga
US Government To Purchase Additional Influenza Treatment From BioCryst For Pandemic Preparedness
August 25, 2022
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.